Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2001, p. 2110-2114, Vol. 39, No. 6
Centers for Disease Control and
Prevention, Atlanta, Georgia1;
Division of Vaccine Research, Institute of Human Virology,
Baltimore, Maryland2; National Institute
for Pharmaceutical Research and Development3
and Federal Ministry of Health,5
Abuja, Nigeria; Robert-Koch Institut, Berlin,
Germany4; and University of Alabama
at Birmingham, Birmingham, Alabama6
Received 26 October 2000/Returned for modification 4 January
2001/Accepted 7 March 2001
The gp120 region of the human immunodeficiency virus type
1 (HIV-1) envelope (env) gene exhibits a high level of
genetic heterogeneity across the group M subtypes. The heteroduplex
mobility assay (HMA) has successfully been used to assign subtype
classifications, but C2V5 primers often fail to amplify African
strains. We developed an env gp41-based HMA for which the
target sequence is amplified with highly conserved gp41 primers, known
to efficiently amplify nucleic acids from HIV-1 group M, N, and O
viruses. By using gp41 from a new panel of reference strains, the
subtype assignments made by our modified HMA were concordant with those
obtained by sequencing and phylogenetic analysis of 34 field strains
from 10 countries representing subtypes A to G. Testing of field
strains from Nigeria further demonstrated the utility of this modified assay. Of 28 samples, all could be amplified with gp41 primers but only
17 (60.7%) could be amplified with the standard C2V5 primers.
Therefore, gp41-based HMA can be a useful tool for the rapid monitoring
of prevalent subtypes in countries with divergent strains of
circulating HIV-1.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2110-2114.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Development of an env gp41-Based
Heteroduplex Mobility Assay for Rapid Human Immunodeficiency Virus Type
1 Subtyping

*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, Mail Stop G19, 1600 Clifton Rd.,
Atlanta, GA 30333. Phone: (404) 639-3957. Fax: (404) 639-2919. E-mail: Mkalish{at}cdc.gov.
Present address: Robert Koch Institute, Berlin, Germany.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»